Literature DB >> 1906912

Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model.

H Redl1, G Schlag, S Bahrami, U Schade, M Ceska, P Stütz.   

Abstract

A hyperdynamic sepsis model was set up in seven adult baboons to evaluate neutrophil-activating peptide-1/interleukin (IL)-8 (NAP-1/IL-8), IL-1 beta, IL-6, tumor necrosis factor-alpha (TNF alpha), and IFN-gamma in plasma. By continuous intravenous administration of 10(10) cfu/kg live Escherichia coli over 8 h with additional infusion therapy (less than or equal to 50 ml/kg/h), endotoxin plasma levels of 2.7-22.3 ng/ml were observed. In plasma the kinetics of NAP-1/IL-8 and IL-6 were similar to those of IL-1 at the end of the experiment (8 h) (peak median values, 34, 4197, and 230 ng/ml, respectively). Differences were greatest for IL-6. Monocyte activation during sepsis was confirmed by elevated plasma neopterin levels (91-139 mumol/mmol of creatine). Granulocyte activation was evident from both incipient neutropenia and the massive release of neutrophil elastase into the plasma as measured by a new immunoassay (peak level, 374 ng/ml). Thus, in primate bacteremia, early TNF release is followed by a concomitant increase of NAP-1/IL-8 with plasma kinetics similar to those of IL-6 and IL-1 and accompanied by massive activation of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906912     DOI: 10.1093/infdis/164.2.383

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  The biphasic immunoregulation of pyrimidylpiperazine (Y-40138) is IL-10 sensitive and requires NF-kappa B targeting in the alveolar epithelium.

Authors:  J J Haddad; B Safieh-Garabedian; N E Saadé; S C Land
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Influence of Gestational Age, Cesarean Section and Hematocrit on lnterleukin-8 Concentrations in Plasma and Detergent-Lysed Whole Blood of Noninfected Newborns.

Authors:  Felix Neunhoeffer; Diana Lipponer; Martin Eichner; Christian F Poets; Annette Wacker; Thorsten W Orlikowsky
Journal:  Transfus Med Hemother       Date:  2011-05-13       Impact factor: 3.747

Review 3.  Choice of bacteria in animal models of sepsis.

Authors:  A S Cross; S M Opal; J C Sadoff; P Gemski
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

4.  Changes in neutrophil CD11b/CD18 and L-selectin expression and release of interleukin 8 and elastase in paediatric cardiopulmonary bypass.

Authors:  A Finn; N Moat; N Rebuck; N Klein; S Strobel; M Elliott
Journal:  Agents Actions       Date:  1993

5.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

6.  Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.

Authors:  T van der Poll; M Levi; H ten Cate; J Jansen; B J Biemond; B L Haagmans; A Eerenberg; S J van Deventer; C E Hack; J W ten Cate
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

7.  Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection.

Authors:  J S Friedland; Y Suputtamongkol; D G Remick; W Chaowagul; R M Strieter; S L Kunkel; N J White; G E Griffin
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

8.  Elevated interleukin-8 levels in the urine of patients with urinary tract infections.

Authors:  Y C Ko; N Mukaida; S Ishiyama; A Tokue; T Kawai; K Matsushima; T Kasahara
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

9.  Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies.

Authors:  C R Amura; R Silverstein; D C Morrison
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

10.  Leukocyte activation by isolated hyperthermic liver and limb perfusion due to malignancy.

Authors:  J P Arnestad; A Bengtsson; J P Bengtson; L Hafström; H Redl; G Schlag
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.